Proteovant Therapeutics
Larry has 20+ years in drug discovery and development of small molecule, biologics, and protein degraders. Previous leadership role at GlaxoSmithKline (GSK), primarily in cardiovascular, renal, and neuroscience therapeutic areas.
This person is not in any offices